In the last trading session, 1.45 million shares of the Tandem Diabetes Care Inc (NASDAQ:TNDM) were traded, and its beta was 1.53. Most recently the company’s share price was $21.48, and it changed around $0.76 or 3.67% from the last close, which brings the market valuation of the company to $1.43B. TNDM currently trades at a discount to its 52-week high of $53.69, offering almost -149.95% off that amount. The share price’s 52-week low was $15.75, which indicates that the current value has risen by an impressive 26.68% since then. We note from Tandem Diabetes Care Inc’s average daily trading volume that its 10-day average is 1.32 million shares, with the 3-month average coming to 1.89 million.
Tandem Diabetes Care Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.17. If we narrow it down even further, the data shows that 0 out of 24 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 11 recommended TNDM as a Hold, whereas 8 deemed it a Buy, and 1 rated it as Underweight.
Tandem Diabetes Care Inc (NASDAQ:TNDM) trade information
Instantly TNDM has showed a green trend with a performance of 3.67% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 23.73 on recent trading dayincreased the stock’s daily price by 9.48%. The company’s shares are currently down -40.37% year-to-date, but still down -5.50% over the last five days. On the other hand, Tandem Diabetes Care Inc (NASDAQ:TNDM) is 18.94% up in the 30-day period. We can see from the shorts that 6.88 million shares have been sold at a short interest cover period of 4.38 day(s).
The consensus price target as assigned by Wall Street analysts is $25, which translates to bulls needing to increase their stock price by 14.08% from its current value. Analyst projections state that TNDM is forecast to be at a low of $22 and a high of $53.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -28.23%. Tandem Diabetes Care Inc earnings are expected to increase by 6.85% in 2025, but the outlook is positive 67.20% per year for the next five years.
TNDM Dividends
Tandem Diabetes Care Inc’s next quarterly earnings report is expected to be released on 2025-Apr-29.
Tandem Diabetes Care Inc (NASDAQ:TNDM)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.94% of Tandem Diabetes Care Inc shares, and 111.54% of them are in the hands of institutional investors. The stock currently has a share float of 112.59%. Tandem Diabetes Care Inc stock is held by 392.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 17.1137% of the shares, which is about 11.12 million shares worth $448.14 million.
VANGUARD GROUP INC, with 11.3518% or 7.38 million shares worth $297.26 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD EXPLORER FUND were the top two Mutual Funds as of Apr 30, 2025 . The former held 3.99 shares worth $85.69 million, making up 5.99% of all outstanding shares. On the other hand, VANGUARD EXPLORER FUND held roughly 2.07 shares worth around $44.47 million, which represents about 3.11% of the total shares outstanding.
